Information For Authors

Our dynamic Author Benefits Program provides you with end-to-end benefits that ensure your hard work pays off and your published manuscript gets the attention it deserves not just upon publication, but permanently.

Journal of Adolescent and Young Adult Oncology (JAYAO) welcomes quantitative and qualitative clinical, basic science, and psychosocial manuscript submissions on all topics related to adolescent and young adult-aged cancer patients and survivors, including AYA-aged survivors of pediatric cancer.

JAYAO generally uses the National Cancer Institute's designated AYA age range of 15-39; however, it is acceptable for manuscripts submitted from institutions or countries typically using a younger lower age limit to use the lower age limit as appropriate. For a discussion about the age range included in adolescent and young adult oncology, please see the Controversies piece in JAYAO's inaugural issue (J Adolesc Young Adult Oncol. 2011;1(1):3-10).

 

Please read all Instructions for Authors carefully before submitting your paper.  All papers are subject to peer review and must be uploaded to the following peer-review website:  https://mc.manuscriptcentral.com/JAYAO

 

Article Types

Note: All articles are peer-reviewed unless otherwise noted. Note the listed limits for text, figures/tables, and references below, but please be concise across all manuscript components. Those interested in an exception to a posted limit must contact the Editors prior to submission.

Original Articles present original quantitative or qualitative basic science, clinical, or psychosocial research

  • Abstract: Standard abstract 250 word limit. See standard abstract guidelines under Manuscript Components.
  • Text: 3,000 word limit.
  • Figures and Tables: Maximum of 8 total figures and/or tables.
  • References: Maximum of 100 references.

Review articles are systematic and critical reviews of the current literature on a topic

  • Abstract: Standard abstract 250 word limit, but structured headings not required.
  • Text: 4,500 word limit. Details on the study selection and inclusion process and on the participants in each selected study should be included.
  • Figures and Tables: Maximum of 10 total figures and/or tables.
  • References: Maximum of 250 references.

Case Study articles are unusual, illustrative, or instructive AYAO-relevant clinical cases

  • Abstract: Include a brief abstract of 100 words or less; structured headings are not required.
  • Text: 1,750 word limit. Include a concise literature review, brief overview of the case, and a brief summarizing conclusion. Be sure to discuss the relevance or importance of the case to AYAO.
  • Figures and Tables: Maximum of 3 total figures and/or tables.
  • References: Maximum of 25 references.

Brief Reports articles are short pieces about pilot studies, preliminary findings, very small sample sizes, or other research findings that are not suitable for a full Original Article

  • Abstract: Include a brief abstract of 100 words or less; structured headings are not required.
  • Text: 2,000 word limit. Include a concise literature review and a brief overview of the study, sufficient details on the study's methods and analysis, and a brief summarizing conclusion.
  • Figures and Tables: Maximum of 3 total figures and/or tables.
  • References: Maximum of 25 references.

Perspective articles are short pieces in which authors share or argue a viewpoint grounded in the literature but not linked to a specific article

  • Abstract: The final print version of accepted Perspective articles will not have an abstract. However, please include a maximum 100 word abstract with the submission to facilitate the review process.
  • Text: 1,500 word limit. The first paragraph should be a brief overview as there is no abstract. The perspective and points should be grounded in the literature. Include a brief summarizing conclusion.
  • Figures and Tables: Maximum of 3 total figures and/or tables.
  • References: Maximum of 25 references.

Letters to the Editor comment on recently published JAYAO articles

  • Special Notes: Letters to the Editor should be submitted within 6 weeks of the article's publication in print form. Include a short title related to but distinct from the recently published article. Provide the standard Title page, but no Running Head or Keywords. The Editors may choose to invite the authors to submit a response to the Letter. Not peer reviewed.
  • Abstract: The final print version of accepted Letters to the Editor will not have an abstract. However, please include a maximum 100 word abstract with the submission to facilitate processing.
  • Text: 500 word limit.
  • Figures and Tables: Maximum of 1 total figure and/or table.
  • References: No more than 5 references, one of which must be the JAYAO article being discussed.


Article Types that are Invite-Only or Require Pre-Submission Inquiry

Roundtable articles are transcribed discussions on a topic by leading members of the AYAO community

  • Invitation only, although those with a suggested topic are welcome to contact the Editors. Not peer reviewed.

Controversies articles include short responses by invited participants to hot topics in AYAO

  • Invitation only, although those with a suggested topic are welcome to contact the Editors. Not peer reviewed.

Clinical Trial Spotlight articles are brief summaries of clinical trials of importance or relevance to AYAO and still open to accrual

  • Invitation only, although those with a suggested topic are welcome to contact the Editors. Not peer reviewed.

Editorial pieces provide commentary and analysis of an article in the issue of JAYAO in which it appears

  • Invitation only. Not peer reviewed.

Book Reviews are 500-750 word pieces critically reviewing a book of AYAO-relevance

  • Invitation only, although those with a suggestion of a book to be reviewed are welcome to contact the Editors. Not peer reviewed.

Special Articles may include guidelines, meeting summaries, consensus statements, or other non-standard communications

  • Please contact the Editors prior to submission. May be subject to peer review.


Online Manuscript Submission

Manuscripts must be uploaded to Manuscript Central in a word processing format, preferably in Microsoft Word. Do not submit the manuscript or any of its components in PDF format. All authors on a submitted manuscript must have a Manuscript Central account.

Keywords and Abstract

Please note the keywords and abstract entered online in Manuscript Central are only to aid with the review process and are separate from the keywords and abstract on the title page for inclusion in the article.

Suggested Reviewers

Authors are encouraged to suggest the names and emails of appropriate reviewers, at least one of whom is not a member of JAYAO’s Editorial Board, during Manuscript Central submission, though final selection of reviewers is at the discretion of the Editors.

Cover Letter

Please include a cover letter from the corresponding author. The cover letter should include the following:

  • Running head character count (including spaces)
  • Abstract word count
  • Main text word count
  • Number of tables
  • Number of figures
  • Number of appendices (if applicable)
  • If the authors have published or submitted any related papers from the same study
  • If pre-submission permission was obtained to exceed the article type’s word limit
  • Authors are encouraged to detail the significance and uniqueness of the work

PUBLICATION ETHICS AND MALPRACTICE STATEMENT

 

Study Design and Ethics

Documented review and approval from a formally constituted review board (Institutional Review Board or Ethics committee) should be required for all studies involving people, medical records, and human tissues. For those investigators who do not have access to formal ethics review committees, the principles outlined in the Declaration of Helsinki should be followed. If the study is judged exempt from review, a statement from the committee should be required. Informed consent by participants should always be secured. If not possible, an institutional review board must decide if this is ethically acceptable. This information should be outlined in the cover letter accompanying the submission, and a sentence declaring adherence should be included in the acknowledgment section of the manuscript.

Animal experiments should require full compliance with local, national, ethical, and regulatory principles, and local licensing arrangements.

Definitions of Scientific Misconduct

Mary Ann Liebert, Inc., publishers generally follows the guidelines and rules regarding scientific misconduct put forth by the Committee on Publication Ethics (COPE), the International Committee of Medical Journal Editors (ICMJE), and the Office of Research Integrity (ORI).

Scientific misconduct and violation of publishing ethics vary and can be intentionally or unintentionally perpetrated. Some examples of misconduct and violations include, but are not limited to, the following:

  • Scientific Misconduct: Fabrication, falsification, concealment, deceptive reporting, or misrepresentation of any data constitutes misconduct and/or fraud.

  •  Authorship Disputes: Deliberate misrepresentation of a scientist’s contribution to the published work, or purposefully omitting the contributions of a scientist.

  • Misappropriation of the ideas of others: Improper use of scholarly exchange and activity may constitute fraud. Wholesale appropriation of such material constitutes misconduct.

  • Violation of generally accepted research practices: Serious deviation from accepted practices in proposing or carrying out research, improper manipulation of experiments to obtain biased results, deceptive statistical or analytical manipulations, or improper reporting of results constitutes misconduct and/or fraud.

  • Material failure to comply with legislative and regulatory requirements affecting research:
    Including but not limited to serious or substantial, repeated, willful violations of applicable local regulations and law involving the use of funds, care of animals, human subjects, investigational drugs, recombinant products, new devices, or radioactive, biologic, or chemical materials constitutes misconduct.

  • Conflict of Interest:  Nondisclosure of any conflicts, direct or indirect, to the Journal which prevents you from being unbiased constitutes misconduct.

  • Deliberate misrepresentation: of qualifications, experience, or research accomplishments to advance the research program, to obtain external funding, or for other professional advancement constitutes misconduct and/or fraud.

  • Plagiarism: Purposely claiming another’s work or idea as your own constitutes misconduct and/or fraud.

  • Simultaneous Submission:  Submitting a paper to more than one publication at the same time constitutes misconduct.

Responding to Allegations of Possible Misconduct

The Publisher is committed to helping protect the integrity of the public scientific record by sharing reasonable concerns with authorities who are in the position to conduct an appropriate investigation into an allegation.  As such, all allegations of misconduct will be referred to the Editor-In-Chief of the Journal who in turn will review the circumstances, possibly in consultation with associate editors and/or members of the editorial board. Initial fact-finding will usually include a request to all the involved parties to state their case and explain the circumstances in writing. In questions of research misconduct centering on methods or technical issues, the Editor-In-Chief may confidentially consult experts who are blinded to the identity of the individuals, or if the allegation is against an editor, an outside expert. The Editor-In-Chief will arrive at a conclusion as to whether there is enough reasonable evidence that the possibility of misconduct occurred.

When allegations concern authors, the peer review and publication process for the manuscript in question will cease while the process described herein is researched. The investigation will be taken to completion even if the authors withdraw their paper.  In the case of allegations against reviewers or editors, they will be replaced in the review process while the matter is investigated.

Editors or reviewers who are found to have engaged in scientific misconduct will be removed from further association with the Journal, and reported to their institution.

If an inquiry concludes there is a reasonable possibility of misconduct, the Editor-in-Chief will retract the paper from the Journal and the scientific record.  If the paper is still under peer review, the Editor-in-Chief will withdraw the paper from consideration to the Journal.

All allegations will be kept confidential.

Manuscript Components

General Formatting and Style

  • Use of English Language: All submissions must be in English. JAYAO uses American-style English
  • Plagiarism: All submitted manuscripts will be processed through plagiarism detection software. Plagiarized manuscripts will be rejected
  • Word limits: See word limits under Article Types. Word limits do not include the Title Page, headings, Abstract, Acknowledgments, Disclaimer, Author Disclosure Statement, References, Figures, Tables, or legends. Permission to exceed an article type’s word limit must be given by the Editors prior to submission
  • Font: Times New Roman or Arial in 12-point type
  • Abbreviations: Expand all abbreviations at first mention in the text
  • Page size: Letter size (8.5 x 11 inches)
  • Margins: 1 inch
  • Line and word spacing: Double-space all lines; single-space all words
  • Page numbering: Number all pages in the lower-right corner. Do not include anything else in the header or footer

Title Page

The title (first) page of all manuscripts must contain the following information:

Exact title:

  • No proprietary names, trade names, or abbreviations

For each author:

  • Full name, including middle initial if applicable
  • Primary academic degrees (such as MD, DO, PhD, MPH, etc. No undergraduate or honorary degrees, fellowship or society memberships, etc.)
  • Institutional affiliation(s)
  • City, state, and country for each affiliation
  • Email address
  • Note:
    • - Group authors (i.e., “…on behalf of the XYZ Study”) are permissible
    • - Co-first authors are also permitted. On the title page, please put an asterisk after each co-first author and note them as such

Corresponding author:

  • Full name, including middle initial if applicable
  • Primary academic degrees (such as MD, DO, PhD, MPH, etc. No undergraduate or honorary degrees, fellowship or society memberships, etc.)
  • Institutional affiliation(s)
  • City, state, and country for each affiliation
  • Full mailing address
  • Phone number
  • Fax number
  • Email address

Running head:

  • 60 characters or fewer (including spaces, abbreviations acceptable)

Keywords:

  • Provide 4-6 keywords to be included in the article
  • Please do not use cancer, oncology, AYA, or adolescent and young adult as these are inherent in the journal itself

Abstract

A structured abstract using the following guidelines should accompany every manuscript unless otherwise noted above under Article Types. The abstract should appear on a separate page after the title page. The abstract should be no more than 250 words, formatted with the following headings:
              - Purpose
              - Methods
              - Results
              - Conclusion

  • Do not use proprietary or trade names
  • References are not permitted in the abstract
  • Headings do not contribute toward abstract word count

Acknowledgments

After the Conclusion of the main body of the manuscript, include a separate section acknowledging any contributors who did not meet the requirements for authorship and any science writers or corporate employees who participated in the development of the manuscript. Also include acknowledgments of research support for the study.

Disclaimer

After the Acknowledgments section, include a “Disclaimer” section, if needed, for the following:

  • Detail any important disclaimers (for example, the primary data collection organization for a secondary-analysis article)
  • Provide all appropriate details if any part of the manuscript was previously presented

Author Disclosure Statement

Following the Acknowledgments section (or Disclaimer if one was included), include a section entitled ‘‘Author Disclosure Statement.’’ Here authors must disclose any commercial associations that might create a conflict of interest in connection with submitted manuscripts. This statement should include appropriate information for EACH author, thereby representing that competing financial interests of all authors have been appropriately disclosed according to the policy of the journal. It is important that all conflicts of interest, whether they are actual or potential, be disclosed. This information will not influence the editorial decision. Please see the Uniform Requirements for Manuscripts Submitted to Biomedical Journals for further guidance. If no conflicts exist, the authors must state ‘‘No competing financial interests exist.’’

References

Authors are responsible for the accuracy and completeness of their references. Number references in the order they are cited in the text; do not alphabetize. In-text citations should be in numerical order, superscripted, not contained within parentheses or brackets, and placed after punctuation.

Reference section:

  • Check the Article Types section for reference number limits for some article types
  • Begin the Reference section on a separate page after the Author Disclosure Statement section
  • Double-space all lines and single-space between words
  • Articles accepted and in press are included in the Reference section
  • Personal communications, unpublished data, or manuscripts “in preparation” or “submitted for publication” should not be included in the Reference section. If necessary, these should be included at the appropriate place in the body of the text. Personal communications should include the contact’s first initial and last name, and the month and year of the communication
  • List all authors and/or editors up to 4; for 5 or more, list the first 3 followed by “et al.”
  • For books, volume and edition numbers should be included when appropriate
  • Abbreviate journal names in accordance with PubMed / MEDLINE   
  • No PMIDs or PCMIDs
  • References that are abstracts should be indicated as such, with the abstract number included, if applicable
  • Citation formats are based on NLM style, please see below for specific JAYAO format examples

Examples:

Journal article with 1-4 authors:

1.   Evan EE, Kaufman M, Cook AB, Zeltzer LK. Sexual health and self-esteem in adolescents and young adults with cancer. Cancer. 2006;107(7 Suppl):1672-9.

Journal article with 5 or more authors:

2.   Absolom K, Eiser C, Michel G, et al. Follow-up care for cancer survivors: views of the younger adult. Br J Cancer. 2009;101(4):561-7.

Abstract:

3.   Mullighan CG, Miller CB, Phillips LA, et al. IKZF1 (Ikaros) deletions are a hallmark of BCR-ABL1 positive acute lymphoblastic leukemia. Blood. 2007;110:abstract 721.

Book:

4.   Quinn GP, Vadaparampil ST (Eds). Reproductive health and cancer in adolescents and young adults. New York: Springer; 2012.

Chapter in a Book:

5.   Eiser C, Kuperberg A. Psychological support for adolescents and young adults. In: Bleyer WA, Barr RD (Eds). Cancer in adolescents and young adults. New York: Springer; 2007; pp. 365-74.

Report:

6.   Adolescent and Young Adult Oncology Progress Review Group. Closing the gap: research and cancer care imperatives for adolescents and young adults with cancer (NIH Publication No. 06-6067). Bethesda, MD: Department of Health and Human Services, National Institutes of Health, National Cancer Institute, and the LIVESTRONG Young Adult Alliance; August 2006. Accessed February 7, 2011 from: http://planning.cancer.gov/library/AYAO_PRG_Report_2006_FINAL.pdf

Tables

Within the text, cite tables in the order in which they appear using Arabic numerals. Tables in accepted articles will be typeset and placed near the first mention of the table in the text; do not include separate lines indicating table placement.

Table guidelines:

  • Check the Article Types section for limits on the number of tables and/or figures for some article types
  • Either prepare all tables on separate pages in the main document following the References section OR submit each table as a separate word processing document. Do not embed tables within the main body text
  • Provide a brief but descriptive title for each table. Avoid abbreviations in the table title when possible
  • Table footnote(s) should include any essential notes and must include definitions of all abbreviations and acronyms used in the table

Figures

Within the text, cite figures in the order in which they appear using Arabic numerals. Figures in accepted articles will be typeset and placed near the first mention of the figure in the text; do not include separate lines indicating figure placement.

Figure guidelines:

  • Check the Article Types section for limits on the number of tables and/or figures for some article types
  • Figures include graphs, charts, diagrams, illustrations, and photographic images
  • File types and guidelines:
    - All figures must be submitted as separate picture files. Do not embed figures in the main word processing document
    - Do not submit figures as PDFs, PowerPoint, or Excel files
    - To ensure proper print quality, please submit only TIFF or EPS files. JPEG files are for screen representation-quality only and will print very poorly during the printing process
    - Line illustrations should be submitted at 900 DPI.  Halftones and color should be submitted at a minimum of 300 DPI
  • Color figures:
    - Color art must be saved as CYMK, not RGB. (Note: If RGB files are submitted, the files will be converted to CYMK and some color variation will occur)
  • Figure legends:
    - After the Reference section of the main word processing document (or any Tables included in the word processing document), include a separate page with the following information for each figure:
    - Provide a brief but descriptive title for each figure. Avoid abbreviations in the figure title when possible
    - Define all relevant information in figures, including figure part labels, footnotes, abbreviations, acronyms, arrows, and levels of magnification in insets

 

Online-Only Materials

Appendices and other supplementary materials should be included only when they are pertinent to the submitted manuscript but beyond the word or table/figure limits.

Appendix and supplementary material guidelines:

  • Published only with the online version of an accepted article
  • The print version of the article will include a URL directing readers to the online-only materials
  • Should be important to understanding or interpretation of the manuscript and limited in length
  • Should be original and not previously published
  • Acceptance of online-only materials is separate from acceptance of the manuscript and at the Editors’ discretion
  • Authors are encouraged to contact the Editors prior to submission of online-only materials

Helpful Hints

  • Clarification of ‘AYA’: Abstracts and the beginning of manuscripts should clearly distinguish whether ‘AYA-aged patients,’ ‘AYA-aged survivors (of AYA cancer),’or ‘AYA-aged survivors (of pediatric cancer)’ are being discussed
  • Variations of ‘AYA’: Authors should use the terminology most appropriate to their manuscript’s age range and country or institution. While ‘adolescent and young adult (AYA)’ is most commonly used in JAYAO, ‘teenage and young adult (TYA),’ ‘young adult (YA),’ adolescent, and other such variations may be used as appropriate
  • Description of age: All manuscripts must clearly state the age range included in both the abstract and main body. Manuscripts discussing survivors must include information about participants’ age both at diagnosis and at study
  • Background and introduction of AYAO in manuscripts: As JAYAO is an entirely AYA-focused journal, please be mindful that the background or introduction section of a manuscript submitted to JAYAO may not need to be as long nor as detailed as an AYAO-focused manuscript submitted to another journal
  • Pre-submission inquiry for manuscripts exceeding word limits: Permission to exceed an article type’s word limit must be given by the Editors prior to submission
  • Revision word limits: Article type word limits apply to revisions as well as initial submissions
  • Pre-submission inquiry for manuscripts with online-only appendices: Authors are encouraged to contact the Editors prior to submission of online-only materials
  • Duplicate author/reviewer accounts in Manuscript Central: Please do not create a duplicate author account when entering authors for a newly-submitted manuscript. If details of an account need to be altered, please contact the Editors
  • Questions and inquiries: Please direct all questions and inquiries to the Editors

 

Permissions

Authors are responsible for procuring permissions to reproduce illustrations or tables taken from other publications and must be acknowledged by a complete credit line in the figure legend. The original publisher’s letter of permission should be available for submission to Journal of Adolescent and Young Adult Oncology if requested by the Editors or the Publisher. A full citation should also be included in the Reference section.

POST-SUBMISSION INFORMATION

Submission-Related Emails and Online Status

The Manuscript Central system sends emails only to the corresponding author (except for copyright release emails for accepted articles). Submitted manuscripts will show in the Manuscript Central Author Center of only the corresponding author.

Manuscript Decisions

Manuscripts may receive decisions of Reject, Major Revision, Minor Revision, Accept with Edits, or Accept. A manuscript decision of Major Revision or Minor Revision does not guarantee the manuscript will ultimately be accepted. Article type word limits apply to revisions as well as initial submissions. A manuscript with a decision of Accept with Edits will not receive a formal Accept decision until all requested edits are satisfactorily completed.

POST-ACCEPTANCE INFORMATION

 Open Access publishing option -- Contact:  OpenAccess@liebertpub.com

 

Page Proofs

An email containing a link to the PDF file of the page proof is sent to the corresponding author. The proof should be read carefully and returned within 3 business days to the Publisher with the author’s/authors’ approval or corrections.

Reprints

Reprints may be ordered by following the special instructions that accompany page proofs and should be ordered at the time the corresponding author returns the corrected page proofs. Reprints ordered after an issue is printed will be charged at a substantially higher rate.

Publisher

Journal of Adolescent and Young Adult Oncology is published bimonthly (six times a year) by Mary Ann Liebert, Inc., 140 Huguenot Street, New Rochelle, NY 10801-5215, Tel: (914) 740-2100; Fax: (914) 740-2101; Email: info@liebertpub.com;  Website: www.liebertpub.com/JAYAO

Liebert Open Access

Ensure maximum visibility, discoverability, and impact for your article with our Liebert Open Access (OA) option

Explore Liebert Open Access

Does your research funder have an open access mandate or would you like to expand the dissemination of your research?

The Liebert Open Access option enables authors to publish open access in our esteemed subscription-based journals.

The benefits of Liebert Open Access include:

  • High visibility; open access articles are freely available online upon publication
  • You retain copyright with the open access license allowing broad dissemination of your research
  • You can freely share your article in repositories and research networks without restrictions
  • Easy compliance with open access mandates
  • Rigorous editorial and peer-review
  • Targeted email announcement featuring a direct link to article

Identification and Marketing

Open access articles are listed with an OA icon in journal tables of content (TOC), TOC alerts, and in marketing announcements. Open access articles are highlighted and promoted in targeted email announcements to thousands of research leaders in your field.

Copyright and Licensing

If you choose to publish with open access, you will retain copyright of your article and a Creative Commons license will be applied. The liberal Creative Commons Attribution 4.0 (CC-BY) license is the default open access license used at Mary Ann Liebert, Inc., publishers. The CC-BY license permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited.

At this time we allow authors to choose between the CC-BY or CC-BY-NonCommercial license. A limited number of journals offer NonCommercial licenses exclusively.

Ordering Open Access

Once your article has been accepted for publication in a journal, you will receive an email with information on ordering Liebert Open Access. If you would like more information about Liebert Open Access or would like to order open access, please email openaccess@liebertpub.com.

Publishing open access includes an article publication charge (APC) and authors are asked to fill out a short open access order form.  You can pay by credit card or receive an invoice to be returned with payment or via bank transfer. Please remember that traditional subscription journals can carry mandatory or optional author fees. The Liebert Open Access APC does not cover or replace existing publication or author fees.

Publishing biomedical or biotechnology research?

Biomedical researchers should consider publishing in BioResearch Open Access, a fully open access peer-reviewed journal dedicated to publishing top research in the biomedical and biotechnology fields. For details, please visit the information for authors on the journal website.

 *Please note that PubMedCentral, not the Publisher, has sole control over when the paper is made live on PMC.

 

Valuable benefits of OA available for download.

Browse journals in the Liebert Open Access portfolio:

NIH Public Access Policy: In order to assist our authors who have NIH funding to comply with this policy, Mary Ann Liebert, Inc. publishers will deposit the final accepted paper (after copy-editing and proofreading) to PubMed Central (PMC) on behalf of the authors. Authors need not take any action. The manuscript's public access posting on PMC will occur 12 months after final publication. This service is provided free of charge. Please note that authors may not deposit manuscripts directly to PMC or other sites without permission from Mary Ann Liebert, Inc.

Publishing in Subscription Journals

By signing the copyright transfer statement, authors still retain a set of rights that allow for self-archiving.

Authors may archive their preprint manuscripts (version prior to peer review) at any time without restrictions. Authors may archive their postprint manuscripts (accepted version after peer review) in institutional repositories, preprint servers, and research networks after a 12 month embargo. The 12 month embargo period begins when the article is published online. Postprints must not be used for commercial purposes and acknowledgement must be given to the final publication, and publisher, by inserting the DOI number of the article in the following sentence: “Final publication is available from Mary Ann Liebert, Inc., publishers http://dx.doi.org/[insert DOI]”. Authors may archive on their personal website without an embargo provided their manuscript is updated with an acknowledgement to the publisher copyright and final published version.

The final published article (version of record) can never be archived in a repository, preprint server, or research network.

 

Publishing Open Access

Authors that wish to easily comply with funder or institutional open access mandates should consider publishing open access. Liebert Open Access option allows authors to make their research freely available online without restrictions. Additionally, Liebert Open Access option allows authors to retain copyright, archive and share the final published version of their article without restrictions. To publish open access please email openaccess@liebertpub.com or visit Liebert Open Access for more information.

The views, opinions, findings, conclusions and recommendations set forth in any Journal article are solely those of the authors of those articles and do not necessarily reflect the views, policy or position of the Journal, its Publisher, its editorial staff or any affiliated Societies and should not be attributed to any of them.